Reference only — not a dosing recommendation.
Product-, indication-, and jurisdiction-specific — see the monograph
- Russian-approved regimens (intranasal solution):
- Acute ischemic stroke (moderate): 12 mg/day × 5–10 days
- Acute ischemic stroke (severe): 18 mg/day × 5–10 days
- Post-stroke recovery: 6 mg/day across two 10-day courses
- Cognitive/nootropic: 0.1% nasal solution, typical course 10–14 days
Studied in trials — not a recommended dose
- Clinical studies used the approved intranasal doses above.
- Long-term or repeated-course safety and efficacy
- Dose for any non-approved indication (cognitive enhancement in healthy adults, neurodegeneration)
- Compatibility with any compounding formulation outside the registered product
Semax — sección de dosis y administración de la monografía